Do Preprints Exaggerate Their Results?

Published Date: 22 Apr 2023

A recent study found that preprints provide spin in addition to new science. F. remarks made by Perry Wilson.

Read Full News

Latest News

S3 Episode 4: Cannabis and Medicinal Mushrooms in Cancer Survivorship

Drs Kathryn J. Ruddy and Stacy D. D'Andre discuss when cannabis, medicinal mushrooms, and psychedelic mushrooms may be useful for treating specific symptoms in patients with cancer.

Aug 08 2025 This Week in Cardiology

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman alert from FDA, and oral anticoagulation choices in elderly patients are discussed by John Mandola, MD, in this week’s podcast.

Episode 4: A Surgeon's Guide to Hidradenitis Suppurativa

Join surgeon Dr Julie Caffrey as she shares her approach to hidradenitis suppurativa surgery, from patient selection to excision, reconstruction, and reducing recurrence.

Jul 18 2025 This Week in Cardiology

Finerenone, what not to consider when choosing treatment of AS, brain health after atrial fibrillation ablation, early rhythm control for AF, and Watchman reimbursement cuts are discussed by John Mandrola, MD, in this week’s podcast.

May 30 2025 This Week in Cardiology

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week’s podcast.

May 23 2025 This Week in Cardiology

Listener feedback on sports “disqualification,” big digoxin news, Brugada syndrome, another positive finerenone study, and unblinded transcatheter trials are discussed by John Mandrola, MD, in this week’s podcast.

Todays Updates

Rheumatology in 2025: Year in Review Victoria Johnson

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Todays Updates

Rheumatology in 2025: Year in Review Victoria Johnson

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Latest News

Drs Kathryn J. Ruddy and Stacy D. D'Andre discuss when cannabis, medicinal mushrooms, and psychedelic mushrooms may be useful for treating specific symptoms in patients with cancer.

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman alert from FDA, and oral anticoagulation choices in elderly patients are discussed by John Mandola, MD, in this week’s podcast.

Join surgeon Dr Julie Caffrey as she shares her approach to hidradenitis suppurativa surgery, from patient selection to excision, reconstruction, and reducing recurrence.

Finerenone, what not to consider when choosing treatment of AS, brain health after atrial fibrillation ablation, early rhythm control for AF, and Watchman reimbursement cuts are discussed by John Mandrola, MD, in this week’s podcast.

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week’s podcast.

Listener feedback on sports “disqualification,” big digoxin news, Brugada syndrome, another positive finerenone study, and unblinded transcatheter trials are discussed by John Mandrola, MD, in this week’s podcast.

News All Time

The Dual Role of Illusion in Patient Care

From painted leaves to placebos, we must balance hope and honesty

The Global Applicability of the DanGer Shock Trial

Positive results were shown for implantation of a mechanical circulatory support device plus standard care for patients presenting with cardiogenic shock and STEMI.

Surprising Mediator Links Poverty and Knee Pain

Study: It's not deprivation per se, but intervening factors that go with it

Sodium Channel Blocker Relieves Acute Pain in Phase III Data

Trials favor a first new class of pain drug in years

No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonists

Conundrum of holding meds continues following conflicting reports of aspiration events

Deep Neuromuscular Blockade Helps Keyhole Surgery, but Not Outcomes Per Se

No impact on safety outcomes after laparoscopic surgery

Stable Angina: A Patient-Centered Approach

A review of the complementary role of coronary revascularization, optimal medical therapy, and lifestyle interventions in the management of stable angina, and the importance of an approach that targets the pathobiology.

Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy

Bowel preparation protocols appeared protective in small study

Sep 27 2024 This Week in Cardiology

Surgical clearance, NICM assessment, dueling perspectives on PCI as first-line therapy for angina, GDMT in HFrEF are the topics John Mandrola, MD, discusses in this week?s podcast.

S2 Episode 5: The Complex Patient With Pulmonary Hypertension and ILD

Drs Jeffrey Swigris and M. Patricia George discuss the complexities of diagnosing and treating pulmonary hypertension in patients with interstitial lung disease.

Laboratory and Radiologic Tests When Assessing a Patient With HF

Dr Kittleson uses the universal heart failure definition to assess symptoms, relying on echocardiograms and natriuretic peptides for diagnosis and classification.

Sep 13 2024 This Week in Cardiology

More from ESC: the SCOFF trial and fasting before cardiac cath, MATTERHORN, humbling data with AI, plus a reflection on the work of being a patient are the topics John Mandrola, MD, covers this week.

Impact of Lp(a) on LDL-C or Apo-B-related Risk of CAD

A comparison of the association between LDL-C and LDL-C corrected for Lp(a)-C (LDLLp(a)corr) with incident coronary heart disease.

Inducing General Anesthesia From the Doctor's Point of View

Watch from the perspective of an anesthesiologist as he prepares a patient to go under the knife

What the Matthew Perry Tragedy Reminds Us About Ketamine Use

We must develop multi-disciplinary safety standards for ketamine clinics

HDL Parameters and Risk of Heart Failure

The association between HDL particle concentration and size with heart failure is studied in participants from the ARIC, MESA, PREVEND, and Dallas Heart studies.

Recommended News For You

investigating radiation oncology applications of artificial general intelligence.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

Study identifies new target for obesity-related breast cancer

GFR-TKIs taken orally in cancer patients who have artery dissection and aneurysms.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

Recommended Articles For You

HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option 

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies 

Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment 

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

2.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

5.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

1.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

2.

All About Ferric Gluconate – The Best Source Of Iron For Anemia

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

5.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

2.

Updates on Standard V/S High Risk Myeloma Treatment

3.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

4.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot